These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 164312

  • 21. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J, Mühlfellner G, Mühlfellner O, Hausmann L, Schubotz R.
    Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of hyperlipoproteinemia type IIa with a "prudent" diet and clofibrate (author's transl)].
    Mertz DP, Suermann J.
    Med Klin; 1978 Jun 09; 73(23):867-73. PubMed ID: 207959
    [Abstract] [Full Text] [Related]

  • 23. Clofibrate decreases jejunal cholesterol synthesis and activity of postheparin plasma lipoprotein lipase in the rat.
    Strandberg TE, Kuusi T, Tilvis RS, Miettinen TA.
    Pharmacology; 1983 Jun 09; 26(5):290-6. PubMed ID: 6856670
    [Abstract] [Full Text] [Related]

  • 24. Influence of dietary cholesterol and fat on serum lipids in men.
    Chenoweth W, Ullmann M, Simpson R, Leveille G.
    J Nutr; 1981 Dec 09; 111(12):2069-80. PubMed ID: 7310532
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Long-term effect of the combination of calcium clofibrate and calcium carbonate on serum total cholesterol, triglyceride and high density lipoprotein--cholesterol concentrations in hyperlipoproteinaemia. A comparative study with clofibrate.
    Lehtonen A, Viikari J.
    Atherosclerosis; 1979 May 09; 33(1):49-58. PubMed ID: 223601
    [Abstract] [Full Text] [Related]

  • 27. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR, Klemens UH, Vollmar LJ, Lang PD.
    Med Klin; 1978 Dec 08; 73(49):1731-7. PubMed ID: 723760
    [Abstract] [Full Text] [Related]

  • 28. The effect of a high cholesterol and saturated fat diet on serum high-density lipoprotein-cholesterol, apoprotein A-I, and apoprotein E levels in normolipidemic humans.
    Tan MH, Dickinson MA, Albers JJ, Havel RJ, Cheung MC, Vigne JL.
    Am J Clin Nutr; 1980 Dec 08; 33(12):2559-65. PubMed ID: 6776798
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
    Hazzard ER, Bierman EL.
    J Lab Clin Med; 1975 Aug 08; 86(2):239-52. PubMed ID: 168277
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
    Jung W, Kremer GJ, Müller D.
    MMW Munch Med Wochenschr; 1975 Oct 31; 117(44):1783-6. PubMed ID: 171564
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Dietary and drug treatment of hyperlipidaemia. A feasibility study in asymptomatic middle-aged men.
    Hedstrand H.
    Ups J Med Sci; 1976 Oct 31; 81(2):85-92. PubMed ID: 183322
    [Abstract] [Full Text] [Related]

  • 35. Dietary fiber and blood lipids: reduction of serum cholesterol in type II hyperlipidemia by guar gum.
    Jenkins DJ, Leeds AR, Slavin B, Mann J, Jepson EM.
    Am J Clin Nutr; 1979 Jan 31; 32(1):16-8. PubMed ID: 216259
    [Abstract] [Full Text] [Related]

  • 36. The influence of clofibrate on lipid and protein components of very low density lipoproteins in type IV hyperlipoproteinaemia.
    Naruszewicz M, Szostak WB, Cybulska C, Kozłowska M, Chotkowska E.
    Atherosclerosis; 1980 Apr 31; 35(4):383-92. PubMed ID: 7378119
    [Abstract] [Full Text] [Related]

  • 37. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P, Schwandt P.
    Verh Dtsch Ges Inn Med; 1980 Apr 31; 83():398-401. PubMed ID: 206058
    [No Abstract] [Full Text] [Related]

  • 38. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975 Apr 31; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of clofibrate on plasma lipids and high-density lipoprotein levels in renal allograft recipients.
    Bagdade JD, Shantharam VV, Sollek M, Albers JJ.
    Clin Nephrol; 1979 Aug 31; 12(2):83-6. PubMed ID: 230927
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.